Biomatrix (BXM) Looking Great Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: pkwknk who wrote (115)	10/9/1997 11:27:00 PM
From: John McCarthy	of 569

pkwknk, Your right of course. I just hope the 4th qtr. has a big top line number. If it does the bottom line will take care of itself. (They have never really shipped more than, say, $2.5 mil. of Synvisc in a qtr.) As for institutional participation and assuming more shares.... Just a guess: they'll have close to $30 mil. in cash at the end of this qtr. (and no use for it) , so I think it would be a split as several folks have mentioned. The only serious R&D going on in '98 is the adhesion product which will be Phase 1/II type costs. At this point, to early to call out what the final gross margin % on synvisc will be. Regards, John McCarthy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next